Literature DB >> 22044953

Dimethyl sulphoxide does not contribute to renal failure in patients undergoing stem cell transplant for multiple myeloma and primary amyloidosis.

Richa Elie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22044953      PMCID： PMC3258997          DOI： 10.2450/2011.0077-10

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  2 in total

1.  Fatal cardiac arrhythmia after infusion of dimethyl sulfoxide-cryopreserved hematopoietic stem cells in a patient with severe primary cardiac amyloidosis and end-stage renal failure.

Authors:  R Zenhäusern; A Tobler; L Leoncini; O M Hess; P Ferrari
Journal:  Ann Hematol       Date:  2000-09       Impact factor: 3.673

2.  Review of 1027 patients with newly diagnosed multiple myeloma.

Authors:  Robert A Kyle; Morie A Gertz; Thomas E Witzig; John A Lust; Martha Q Lacy; Angela Dispenzieri; Rafael Fonseca; S Vincent Rajkumar; Janice R Offord; Dirk R Larson; Matthew E Plevak; Terry M Therneau; Philip R Greipp
Journal:  Mayo Clin Proc       Date:  2003-01       Impact factor: 7.616
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.